Literature DB >> 17982878

Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis.

F Tribl1, T Arzberger, P Riederer, M Gerlach.   

Abstract

Catecholaminergic neurons of the primate substantia nigra (SN) pars compacta (SNc) and the locus coeruleus contain neuromelanin (NM) granules as characteristic structures underlying the pigmentation of these brain areas. Due to a phylogenetic appearance NM granules are absent in the rodent brain, but gradually become present in primates until they reach a maximal expression in humans. Although a possible mechanism of pigment formation may be autoxidation of the NM precursors dopamine or noradrenalin, several groups have suggested an enzymatic formation of NM mediated by tyrosinase or a related enzyme. Since tyrosinase mRNA is suggested to be expressed in the SN of mice and humans, we reinvestigated the expression of tyrosinase in the human SNc and the locus coeruleus at the protein level by immunohistochemistry and Western blot analysis, but could not detect tyrosinase in these brain regions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982878     DOI: 10.1007/978-3-211-73574-9_8

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  20 in total

1.  Metazoan innovation: from aromatic amino acids to extracellular signaling.

Authors:  Katrina M Kutchko; Jessica Siltberg-Liberles
Journal:  Amino Acids       Date:  2013-05-21       Impact factor: 3.520

Review 2.  Neuromelanin of the human substantia nigra: an update.

Authors:  Fabio A Zucca; Emy Basso; Francesca A Cupaioli; Emanuele Ferrari; David Sulzer; Luigi Casella; Luigi Zecca
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

Review 3.  Copper active sites in biology.

Authors:  Edward I Solomon; David E Heppner; Esther M Johnston; Jake W Ginsbach; Jordi Cirera; Munzarin Qayyum; Matthew T Kieber-Emmons; Christian H Kjaergaard; Ryan G Hadt; Li Tian
Journal:  Chem Rev       Date:  2014-03-03       Impact factor: 60.622

Review 4.  Neuromelanin in Parkinson's Disease: from Fenton Reaction to Calcium Signaling.

Authors:  Rainer Knörle
Journal:  Neurotox Res       Date:  2017-09-06       Impact factor: 3.911

5.  QTL underlying voluntary exercise in mice: interactions with the "mini muscle" locus and sex.

Authors:  Derrick L Nehrenberg; Shiliang Wang; Robert M Hannon; Theodore Garland; Daniel Pomp
Journal:  J Hered       Date:  2010 Jan-Feb       Impact factor: 2.645

Review 6.  Melanin affinity and its possible role in neurodegeneration.

Authors:  Oskar Karlsson; Nils Gunnar Lindquist
Journal:  J Neural Transm (Vienna)       Date:  2013-07-03       Impact factor: 3.575

7.  Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease.

Authors:  Fabio A Zucca; Renzo Vanna; Francesca A Cupaioli; Chiara Bellei; Antonella De Palma; Dario Di Silvestre; Pierluigi Mauri; Sara Grassi; Alessandro Prinetti; Luigi Casella; David Sulzer; Luigi Zecca
Journal:  NPJ Parkinsons Dis       Date:  2018-06-05

Review 8.  Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease.

Authors:  Fabio A Zucca; Juan Segura-Aguilar; Emanuele Ferrari; Patricia Muñoz; Irmgard Paris; David Sulzer; Tadeusz Sarna; Luigi Casella; Luigi Zecca
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

9.  Proteomic characterization of neuromelanin granules isolated from human substantia nigra by laser-microdissection.

Authors:  Sarah Plum; Simone Steinbach; Johannes Attems; Sharon Keers; Peter Riederer; Manfred Gerlach; Caroline May; Katrin Marcus
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

Review 10.  Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models.

Authors:  Andrea Capucciati; Fabio A Zucca; Enrico Monzani; Luigi Zecca; Luigi Casella; Tim Hofer
Journal:  Antioxidants (Basel)       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.